Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Pathogens (Basel, Switzerland)
|
July 26, 2024
Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy
Robyn-Brooke Labuschagne Naidoo, Helen C Steel, Annette J Theron, et al.
Medicina (Kaunas, Lithuania)
|
November 27, 2025
Immunopathogenesis and Therapeutic Implications in Basal Cell Carcinoma: Current Concepts and Future Directions
Helen C Steel, Theresa M Rossouw, Ronald Anderson, et al.
Journal of Global Antimicrobial Resistance
|
March 27, 2022
Assessment of the efficacy of clofazimine alone and in combination with primary agents against Mycobacterium tuberculosis in vitro
Sizeka A Mashele, Helen C Steel, Maborwa T Matjokotja, et al.
Viruses
|
September 28, 2024
Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study
Crystal G Roux, Shayne Mason, Louise D V du Toit, et al.
Frontiers in Immunology
|
March 15, 2021
Submission for Special Issue: The Role of Platelet Activation in the Pathophysiology of HIV, Tuberculosis, and Pneumococcal Disease. Bedaquiline Suppresses ADP-Mediated Activation of Human Platelets <i>In Vitro via</i> Interference With Phosphatidylinositol 3-Kinase
Gregory R Tintinger, Annette J Theron, Helen C Steel, et al.
Frontiers in Immunology
|
February 15, 2021
Differential Responsiveness of the Platelet Biomarkers, Systemic CD40 Ligand, CD62P, and Platelet-Derived Growth Factor-BB, to Virally-Suppressive Antiretroviral Therapy
Helen C Steel, W D Francois Venter, Annette J Theron, et al.
Current Issues in Molecular Biology
|
May 27, 2026
Triple-Negative Breast Cancer: Molecular Subtypes; Immune Escape; Limitations of Current Immunotherapy; and the BTLA/HVEM/CD160 Axis as an Emerging Target
Bernardo L Rapoport, Ronald Anderson, Daniel van Tonder, et al.
Mediators of Inflammation
|
May 9, 2014
Circulating biomarkers of immune activation distinguish viral suppression from nonsuppression in HAART-treated patients with advanced HIV-1 subtype C infection
Glen Malherbe, Helen C Steel, Sharon Cassol, et al.
Free Radical Biology & Medicine
|
December 13, 2005
Vanadium promotes hydroxyl radical formation by activated human neutrophils
Heidi Fickl, Annette J Theron, Heidi Grimmer, et al.
Frontiers in Immunology
|
August 30, 2023
Comparison of platelet-and endothelial-associated biomarkers of disease activity in people hospitalized with Covid-19 with and without HIV co-infection
Mieke A van der Mescht, Helen C Steel, Zelda de Beer, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Pathogens (Basel, Switzerland)
|
July 26, 2024
Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy
Robyn-Brooke Labuschagne Naidoo, Helen C Steel, Annette J Theron, et al.
Medicina (Kaunas, Lithuania)
|
November 27, 2025
Immunopathogenesis and Therapeutic Implications in Basal Cell Carcinoma: Current Concepts and Future Directions
Helen C Steel, Theresa M Rossouw, Ronald Anderson, et al.
Journal of Global Antimicrobial Resistance
|
March 27, 2022
Assessment of the efficacy of clofazimine alone and in combination with primary agents against Mycobacterium tuberculosis in vitro
Sizeka A Mashele, Helen C Steel, Maborwa T Matjokotja, et al.
Viruses
|
September 28, 2024
Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study
Crystal G Roux, Shayne Mason, Louise D V du Toit, et al.
Frontiers in Immunology
|
March 15, 2021
Submission for Special Issue: The Role of Platelet Activation in the Pathophysiology of HIV, Tuberculosis, and Pneumococcal Disease. Bedaquiline Suppresses ADP-Mediated Activation of Human Platelets <i>In Vitro via</i> Interference With Phosphatidylinositol 3-Kinase
Gregory R Tintinger, Annette J Theron, Helen C Steel, et al.
Frontiers in Immunology
|
February 15, 2021
Differential Responsiveness of the Platelet Biomarkers, Systemic CD40 Ligand, CD62P, and Platelet-Derived Growth Factor-BB, to Virally-Suppressive Antiretroviral Therapy
Helen C Steel, W D Francois Venter, Annette J Theron, et al.
Current Issues in Molecular Biology
|
May 27, 2026
Triple-Negative Breast Cancer: Molecular Subtypes; Immune Escape; Limitations of Current Immunotherapy; and the BTLA/HVEM/CD160 Axis as an Emerging Target
Bernardo L Rapoport, Ronald Anderson, Daniel van Tonder, et al.
Mediators of Inflammation
|
May 9, 2014
Circulating biomarkers of immune activation distinguish viral suppression from nonsuppression in HAART-treated patients with advanced HIV-1 subtype C infection
Glen Malherbe, Helen C Steel, Sharon Cassol, et al.
Free Radical Biology & Medicine
|
December 13, 2005
Vanadium promotes hydroxyl radical formation by activated human neutrophils
Heidi Fickl, Annette J Theron, Heidi Grimmer, et al.
Frontiers in Immunology
|
August 30, 2023
Comparison of platelet-and endothelial-associated biomarkers of disease activity in people hospitalized with Covid-19 with and without HIV co-infection
Mieke A van der Mescht, Helen C Steel, Zelda de Beer, et al.
Page
of 6